PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZVNBX vs. FXH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ZVNBX and FXH is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

ZVNBX vs. FXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zevenbergen Growth Fund (ZVNBX) and First Trust Health Care AlphaDEX Fund (FXH). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
17.14%
-3.11%
ZVNBX
FXH

Key characteristics

Sharpe Ratio

ZVNBX:

1.05

FXH:

0.25

Sortino Ratio

ZVNBX:

1.50

FXH:

0.43

Omega Ratio

ZVNBX:

1.19

FXH:

1.05

Calmar Ratio

ZVNBX:

0.56

FXH:

0.16

Martin Ratio

ZVNBX:

5.73

FXH:

0.81

Ulcer Index

ZVNBX:

4.30%

FXH:

3.90%

Daily Std Dev

ZVNBX:

23.56%

FXH:

12.58%

Max Drawdown

ZVNBX:

-66.93%

FXH:

-43.70%

Current Drawdown

ZVNBX:

-21.74%

FXH:

-14.36%

Returns By Period

In the year-to-date period, ZVNBX achieves a 3.89% return, which is significantly lower than FXH's 4.47% return.


ZVNBX

YTD

3.89%

1M

0.77%

6M

17.14%

1Y

27.68%

5Y*

10.75%

10Y*

N/A

FXH

YTD

4.47%

1M

0.62%

6M

-3.12%

1Y

3.35%

5Y*

4.43%

10Y*

5.51%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ZVNBX vs. FXH - Expense Ratio Comparison

ZVNBX has a 1.30% expense ratio, which is higher than FXH's 0.61% expense ratio.


ZVNBX
Zevenbergen Growth Fund
Expense ratio chart for ZVNBX: current value at 1.30% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.30%
Expense ratio chart for FXH: current value at 0.61% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.61%

Risk-Adjusted Performance

ZVNBX vs. FXH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZVNBX
The Risk-Adjusted Performance Rank of ZVNBX is 5555
Overall Rank
The Sharpe Ratio Rank of ZVNBX is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of ZVNBX is 5555
Sortino Ratio Rank
The Omega Ratio Rank of ZVNBX is 5353
Omega Ratio Rank
The Calmar Ratio Rank of ZVNBX is 4444
Calmar Ratio Rank
The Martin Ratio Rank of ZVNBX is 6868
Martin Ratio Rank

FXH
The Risk-Adjusted Performance Rank of FXH is 1111
Overall Rank
The Sharpe Ratio Rank of FXH is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of FXH is 1010
Sortino Ratio Rank
The Omega Ratio Rank of FXH is 1010
Omega Ratio Rank
The Calmar Ratio Rank of FXH is 1111
Calmar Ratio Rank
The Martin Ratio Rank of FXH is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZVNBX vs. FXH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zevenbergen Growth Fund (ZVNBX) and First Trust Health Care AlphaDEX Fund (FXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZVNBX, currently valued at 1.05, compared to the broader market-1.000.001.002.003.004.001.050.25
The chart of Sortino ratio for ZVNBX, currently valued at 1.50, compared to the broader market0.002.004.006.008.0010.0012.001.500.43
The chart of Omega ratio for ZVNBX, currently valued at 1.19, compared to the broader market1.002.003.004.001.191.05
The chart of Calmar ratio for ZVNBX, currently valued at 0.56, compared to the broader market0.005.0010.0015.0020.000.560.16
The chart of Martin ratio for ZVNBX, currently valued at 5.73, compared to the broader market0.0020.0040.0060.0080.005.730.81
ZVNBX
FXH

The current ZVNBX Sharpe Ratio is 1.05, which is higher than the FXH Sharpe Ratio of 0.25. The chart below compares the historical Sharpe Ratios of ZVNBX and FXH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
1.05
0.25
ZVNBX
FXH

Dividends

ZVNBX vs. FXH - Dividend Comparison

ZVNBX has not paid dividends to shareholders, while FXH's dividend yield for the trailing twelve months is around 0.40%.


TTM202420232022
ZVNBX
Zevenbergen Growth Fund
0.00%0.00%0.00%0.00%
FXH
First Trust Health Care AlphaDEX Fund
0.40%0.41%0.24%0.20%

Drawdowns

ZVNBX vs. FXH - Drawdown Comparison

The maximum ZVNBX drawdown since its inception was -66.93%, which is greater than FXH's maximum drawdown of -43.70%. Use the drawdown chart below to compare losses from any high point for ZVNBX and FXH. For additional features, visit the drawdowns tool.


-40.00%-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%SeptemberOctoberNovemberDecember2025February
-21.74%
-14.36%
ZVNBX
FXH

Volatility

ZVNBX vs. FXH - Volatility Comparison

Zevenbergen Growth Fund (ZVNBX) has a higher volatility of 5.89% compared to First Trust Health Care AlphaDEX Fund (FXH) at 4.06%. This indicates that ZVNBX's price experiences larger fluctuations and is considered to be riskier than FXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
5.89%
4.06%
ZVNBX
FXH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab